Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2023.12.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Christopher D Mansi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Thomas Jefferso…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Hemostatics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Heart Association Inc, NHLBI.
Abstract (Originalsprache)
BACKGROUND: Antithrombotic medications carry an inherent risk of bleeding, which may be exacerbated when anticoagulant and antiplatelet therapeutics are combined. Prior studies have shown different effects of antiplatelet vs anticoagulant drugs on the structure and function of hemostatic plugs in vivo. OBJECTIVES: We examined whether dual antithrombotic treatment consisting of combined antiplatelet and anticoagulant therapeutics alters hemostatic plug structure and function differently from treatment with either therapeutic alone. METHODS: Mice were treated with the P2Y12 antagonist clopidogrel and the factor Xa inhibitor rivaroxaban across a range of doses, either alone or in combination. The hemostatic response was assessed using a mouse jugular vein puncture injury model. Platelet accumulation and fibrin deposition were evaluated using quantitative multiphoton fluorescence microscopy, and bleeding times were recorded. RESULTS: Mice treated with clopidogrel alone exhibited a decrease in platelet accumulation at the site of injury, with prolonged bleeding times only at the highest doses of clopidogrel used. Mice treated with rivaroxaban alone instead showed a reduction in fibrin deposition with no impact on bleeding. Mice treated with both clopidogrel and rivaroxaban exhibited platelet and fibrin accumulation that was similar to that with either drug given alone; however, dual antithrombotic therapy resulted in impaired hemostasis at doses that had no impact on bleeding when given in isolation. CONCLUSION: Combined administration of antiplatelet and anticoagulant therapeutics exacerbates bleeding as compared to that with either drug alone, potentially via combined loss of both adenosine 5'-diphosphate- and thrombin-mediated platelet activation. These findings enhance our understanding of the bleeding risk associated with dual antithrombotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: Tim…
Förderung
- NHLBI NIH HHS
- American Heart Association Inc
- NHLBI
Zitieren
APA
Mansi, C. D., Severa, J. R., Wilhelm, J. N., Marar, T. T., Roberts, M. E., Zhao, X., & Stalker, T. J. (2024). Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.12.017
Vancouver
Mansi CD, Severa JR, Wilhelm JN, Marar TT, Roberts ME, Zhao X, et al. Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.12.017
BibTeX
@article{Mansi2024,
author = {Mansi, Christopher D and Severa, Jenna R and Wilhelm, Joseph N and Marar, Tanya T and Roberts, Meghan E and Zhao, Xuefei and Stalker, Timothy J},
title = {Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2023.12.017}
}
EUVIMED